Cargando…

Immunohistochemical analysis of matrix metalloproteinase-9 predicts papillary thyroid carcinoma prognosis

The present study aimed to explore the association between immunohistochemical matrix metalloproteinase-9 (MMP-9) expression and the clinicopathological characteristics of patients with papillary thyroid carcinoma (PTC), and to determine whether it may be used as a diagnostic or prognostic tool for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Xingkai, Su, Chang, Xu, Jing, Zhou, Dan, Yan, He, Li, Wei, Chen, Guihui, Zhang, Nan, Xu, Dahai, Hu, Haixia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2019
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6341782/ https://www.ncbi.nlm.nih.gov/pubmed/30675296 http://dx.doi.org/10.3892/ol.2018.9850

Ejemplares similares

Enhanced activation of matrix metalloproteinase-9 correlates with the degree of papillary thyroid carcinoma infiltration
por: Marečko, Ilona, et al.
Publicado: (2014)

Predictive Significance of Serum MMP-9 in Papillary Thyroid Carcinoma
por: Xu, Dahai, et al.
Publicado: (2019)

Clinical significance of matrix metalloproteinase-9 expression in papillary thyroid carcinoma: a meta-analysis
por: Wen, Jinxu, et al.
Publicado: (2023)

The role of matrix metalloproteinase-9 as a prognostic biomarker in papillary thyroid cancer
por: Zarkesh, Maryam, et al.
Publicado: (2018)

Clinical value of matrix metalloproteinase-2 and -9 in ultrasound-guided radiofrequency ablation treatment for papillary thyroid carcinoma
por: Pan, Qunyan, et al.
Publicado: (2020)

Immunohistochemical expression of osteonectin, matrix metalloproteinases-9 and Ki-67 in ameloblastoma
por: Indirapriyadarsini, K, et al.
Publicado: (2018)

Overexpression of G Protein-Coupled Receptor Kinase 6 (GRK6) Is Associated with Progression and Poor Prognosis of Papillary Thyroid Carcinoma
por: Che, Xiaoqi, et al.
Publicado: (2018)

Serum MMP-2 as a potential predictive marker for papillary thyroid carcinoma
por: Shi, Yunpeng, et al.
Publicado: (2018)

Expression of matrix metalloproteinase-9 in histological grades of oral squamous cell carcinoma: An immunohistochemical study
por: Patil, Rekha, et al.
Publicado: (2021)

Role of Matrix Metalloproteinases and Their Inhibitors in Locally Invasive Papillary Thyroid Cancer
por: Ivković, Irena, et al.
Publicado: (2022)

Matrix metalloproteinase-7 and matrix metalloproteinase-9 are associated with unfavourable prognosis in superficial oesophageal cancer
por: Tanioka, Y, et al.
Publicado: (2003)

Immunohistochemical detection of membrane-type-1-matrix metalloproteinase in colorectal carcinoma
por: Kikuchi, R, et al.
Publicado: (2000)

Immunohistochemical expression of ER-α and PR in papillary thyroid carcinoma
por: Eldien, Marwa Mohammed Serag, et al.
Publicado: (2017)

Expression levels of matrix metalloproteinase-9 in human gastric carcinoma
por: CHEN, SU-ZUAN, et al.
Publicado: (2015)

Prognosis of Multifocal Papillary Thyroid Carcinoma
por: Kuo, Sheng-Fong, et al.
Publicado: (2013)

The Correlation between Proliferative Immunohistochemical Markers and Papillary Thyroid Carcinoma Aggressiveness
por: Sheikh-Ahmad, Mohammad, et al.
Publicado: (2023)

CDK9 is up-regulated and associated with prognosis in patients with papillary thyroid carcinoma
por: Guo, Tao, et al.
Publicado: (2022)

Immunohistochemical Analysis of Matrix Metalloproteinase-13 in Human Caries Dentin
por: Loreto, C., et al.
Publicado: (2014)

Epigallocatechin-3-gallate inhibits migration and invasion of human renal carcinoma cells by downregulating matrix metalloproteinase-2 and matrix metalloproteinase-9
por: CHEN, SHAO-JUN, et al.
Publicado: (2016)

Immunohistochemical expression of vascular endothelial growth factor and matrix metalloproteinase-9 in radicular and residual radicular cysts
por: RUIZ, Patrícia Alvarez, et al.
Publicado: (2010)

Impact of pregnancy on papillary thyroid carcinoma prognosis
por: Driouich, Yasmine, et al.
Publicado: (2021)

Is obesity associated with the prognosis of papillary thyroid carcinoma?
por: Kim, Jung Min
Publicado: (2022)

Relationship between Trace Elements and Matrix Metalloproteinases 2 and 9 and their Tissue Inhibitors in Medullary Thyroid Carcinoma
por: Vázquez-Lorente, Héctor, et al.
Publicado: (2022)

Expression and Concentration of Matrix Metalloproteinase 9 and Tissue Inhibitor of Matrix Metalloproteinases 1 in Laryngeal Squamous Cell Carcinoma
por: Matulka, Marlena, et al.
Publicado: (2019)

Immunohistochemical Correlation of Matrix Metalloproteinase-2 and Tissue Inhibitors of Metalloproteinase-2 in Tobacco Associated Epithelial Dysplasia
por: Bajracharya, Dipshikha, et al.
Publicado: (2014)

Potent and selective inhibition of matrix metalloproteinases by lanthanide trichloride
por: Wang, Yanyan, et al.
Publicado: (2018)

Lower Serum Matrix Metalloproteinase‑9 in Metastatic Patients with Esophageal Squamous Cell Carcinoma After Concurrent Radiotherapy Was Significant for Prognosis
por: Ye, Ziqi, et al.
Publicado: (2020)

Extracellular matrix metalloproteinase inducer expression in histological grades of oral squamous cell carcinoma – An immunohistochemical study
por: Khan, Sabiha Mohiddin, et al.
Publicado: (2020)

Immunohistochemical Analysis of Toll-Like Receptors, MyD88, and TRIF in Human Papillary Thyroid Carcinoma and Anaplastic Thyroid Carcinoma
por: Nihon-Yanagi, Yasuhiro, et al.
Publicado: (2021)

EpCAM (MOC-31) – immunohistochemical expression in papillary thyroid carcinoma and non invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP)
por: Ben Rejeb, Sarra, et al.
Publicado: (2021)

Immunohistochemical Demonstration of Membrane-bound Prostaglandin E(2) Synthase-1 in Papillary Thyroid Carcinoma
por: Omi, Yoko, et al.
Publicado: (2009)

Papillary microcarcinomas of the thyroid gland and immunohistochemical analysis of expression of p53 protein in papillary microcarcinomas
por: Corapcioglu, Demet, et al.
Publicado: (2006)

Matrix metalloproteinase-9 overexpression is closely related to poor prognosis in patients with colon cancer
por: Yang, Bo, et al.
Publicado: (2014)

Fluctuating Roles of Matrix Metalloproteinase-9 in Oral Squamous Cell Carcinoma
por: Vilen, Suvi-Tuuli, et al.
Publicado: (2013)

Assessment and clinicopathological correlation of matrix metalloproteinase 9 expression in nasopharyngeal carcinoma
por: Das, Ashok Kumar, et al.
Publicado: (2019)

Interleukin-33, matrix metalloproteinase-9, and tissue ınhibitor of matrix metalloproteinase-1 in myocardial infarction
por: Guzel, Savas, et al.
Publicado: (2013)

Interplay between Matrix Metalloproteinase-9, Matrix Metalloproteinase-2, and Interleukins in Multiple Sclerosis Patients
por: Trentini, Alessandro, et al.
Publicado: (2016)

Matrix Metalloproteinase-1 and Matrix Metalloproteinase-9 in the Aqueous Humor of Diabetic Macular Edema Patients
por: Kwon, Jin-woo, et al.
Publicado: (2016)

Matrix metalloproteinases in keratinocyte carcinomas
por: Riihilä, Pilvi, et al.
Publicado: (2020)

Matrix Metalloproteinase 1, 3, and 9 Polymorphisms and Esophageal Squamous Cell Carcinoma Risk
por: Guan, Xuan, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_qpm4lmasnibdu0528u84gvjqj4